Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02652078 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Shockwave Therapy in Lower Limb Intermittent Calf Claudication

Study acronym: ESWT
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv12
  2. Study completion date: Oct 31, 2025 to Feb 1, 2030v11
  3. Publications: details revised at 1 of 4 entriesv10
  4. Enrollment target: estimated 100 to confirmed 138
    • Study completion date: Jun 2022 to Oct 31, 2025
    v9
  5. Primary completion date: Sep 30, 2019 to Jul 31, 2020
    • Study completion date: Jun 2021 to Jun 2022
    • Start date: Jun 2015 to May 11, 2015
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jul 2020 to Jun 2021
    • Site details revised
    v7
  2. Primary completion date changed from estimate of Nov 2019 to Sep 30, 2019v6
  3. Primary completion date: Oct 2019 to Nov 2019v5
  4. Primary completion date: Sep 2019 to Oct 2019v4
  5. Lead sponsor: University of Hull to Hull University Teaching Hospitals NHS Trustv3 Show 4 more changesShow less
    • Primary completion date: Jun 2017 to Sep 2019
    • Study completion date: Jun 2018 to Jul 2020
    • Publications: details revised at 1 of 4 entries
    • Collaborators expanded, about 3 words
  6. Primary completion date: Jan 2016 to Jun 2017
    • Study completion date: Apr 2016 to Jun 2018
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Peripheral arterial disease is a common condition affecting approximately 64% of 56-77 year olds. This condition restricts bloody supply to calf muscles. Pain occurs after walking a short distance and increases in intensity until the person stops, where the pain then gradually subsides. It can be limiting or occasionally debilitating and has been shown to have considerable deleterious effects of patients quality of life. Shock wave therapy has been shown to promote new blood vessel formation and improved healing amongst other findings. This study aims to identify whether shock wave therapy that is applied to the calf muscles causes such an effect to improve the blood supply to the calf muscles, reduce pain, improve walking ability and quality of life.
Trial Details
NCT Number NCT02652078
Lead Sponsor Hull University Teaching Hospitals NHS Trust
Collaborators: University of Hull
Conditions
(from sponsor)		 Peripheral Vascular Disease
Related terms Peripheral Vascular Diseases
Enrollment 138 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov